BBIOBridgeBio Pharma, Inc.

$79.37

Is it safe?

Can BBIO take a bad year?

The deepest fall in BBIO's price history on file is −93%; it is −7.6% below its high today.

$1.93B

Net debt · as at Q2 2026 · debt less the cash on hand

Altman Z-score
-3.65

Altman Z-score · distress zone, below 1.8

Cash runway
1.6 years

Cash runway · burning $109M a quarter at the current rate

Annualised volatility
53%

Annualised volatility · roughly twice as jumpy as the market

Details
Total debtQ2 2026
$2.65B
Cash and short-term investments
$720M
Net debt
$1.93B
EBITDA, trailing twelve months
−$494M
Operating profit, trailing twelve months
−$498M
Annualised volatilitytwo years of daily moves
53%
Worst drawdown on file
−93%
Below its 52-week high
−7.6%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.